Phase 4
Completed N=120
Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
Source: ClinicalTrials.gov NCT01607203 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcomePrimary: MII Oocytes — 9.2; 10.3 cumulus oocyte complex
Summary
The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY MII Oocytes |
9.2; 10.3 | — |
| SECONDARY Pregnancy Rate |
28; 45 | — |
| SECONDARY Patients With Cryopreserved Embryos |
21; 33 | 0.04 sig |
Eligibility Criteria
Inclusion Criteria
- Intra-cytoplasmic sperm injection (ICSI) patients below 38 years
- 1,2 or 3 rd IVF-cycle
Exclusion Criteria
- polycystic ovary syndrome (PCOS) patients
- patients with endocrinological diseases or problems
Data sourced from ClinicalTrials.gov (NCT01607203). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.